2 results
Approved WMOCompleted
To determine if emixustat hydrochloride (emixustat) reduces the rate of progression of macular atrophy (MA) compared to placebo in subjects with Stargardt disease (STGD)1. To evaluate the safety and tolerability of emixustat compared to placebo2. To…
Approved WMORecruiting
The primary objective is to determine the usability of the bony bridging score and to investigate the degree of radiological bone ingrowth in patients who are eligible for a lumbar spinal fusion with PLIF (EIT®) cages.